Sedat Evran - 20 Oct 2026 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Reporting relationship: EVP, Global Supply Chain
Issuer ticker: BIO
Reported as of: 20 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Oct 2026, 17:55:06 UTC
Prior SEC filing: 09 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Sedat Evran

Filing notes and source

Key filing fact

Sedat Evran filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 22 Oct 2026.

Key facts

This page summarizes Sedat Evran's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Oct 2026, 17:55.

Change

Previous filing in this sequence was filed on 09 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001993147 Primary reporting owner

EVRAN SEDAT

Relationship: EVP, Global Supply Chain
Address: C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES
Signature: /s/ Sedat Evran
Signature date: 22 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIO transaction

Bio-Rad A Common Stock

Options Exercise

Transaction value
Shares: +1,044
Change %: +29%
Price: $0.000000^*
Shares after: 4,647
Date: 20 Oct 2026
Ownership: Direct
Footnotes: F1

BIO transaction

Bio-Rad A Common Stock

Tax liability

Transaction value
Shares: -487
Change %: -10%
Price: $354.50^*
Shares after: 4,160
Date: 20 Oct 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIO transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -1,044
Change %: -50%
Price: $0.000000^*
Shares after: 1,044
Date: 20 Oct 2026
Ownership: Direct
Underlying class: Bio-Rad A Common Stock
Underlying amount: 1,044
Exercise price: $0.000000
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares of Class A common stock acquired on the vesting of restricted stock units.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

Footnote F3

On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.